Funding · Company
Arda Therapeutics, Inc.
San Carlos, CABiotech & Pharma
Arda Therapeutics, Inc. of San Carlos, CA has disclosed $43M across 1 Form D offering filed with the SEC on Oct 2, 2024.
$43M
Total disclosed
1
Form D offering
2021
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$43M
Form D · Oct 2, 2024 ↗
Q4 2024
· target $43M
Filing details
HeadquartersSan Carlos, CAIndustryBiotech & Pharma (Biotechnology)Incorporated2021SEC CIK0001903317Offerings on file1
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →